Improving oncolytic virus immunotherapy for the treatment of cancer (360G-Wellcome-212913_Z_18_Z)
Funding Organization
£0
Recipient Organization
The aims of the project are to develop and select the most effective maraba oncolytic viruses (OV), encoding genes into the maraba virus in order to enhance an anti-tumour response through immune priming, to be taken forward into clinical testing for the treatment of advanced melanoma.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded |
0
|
| Applicant Surname | Armstrong |
| Approval Committee | Internal Decision Panel |
| Award Date | 2018-09-30T00:00:00+00:00 |
| Financial Year | 2017/18 |
| Grant Programme: Title | PhD Training Fellowship for Clinicians |
| Internal ID | 212913/Z/18/Z |
| Lead Applicant | Dr Edward Armstrong |
| Partnership Value | 0 |
| Planned Dates: End Date | 2021-07-21T00:00:00+00:00 |
| Planned Dates: Start Date | 2018-01-22T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | Greater London |